Open AccessRetrospective analysis of diabetic foot osteomyelitis management and outcome at a tertiary care hospital in the UK
Author(s) -
M.L. del Pilar Reyna Arias,
Sittiga Hassan-Reshat,
William Newsholme
Publication year - 2019
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0216701
Subject(s) - medicine , linezolid , osteomyelitis , vancomycin , amputation , diabetic foot , meropenem , diabetic foot ulcer , antibiotics , retrospective cohort study , surgery , staphylococcus aureus , methicillin resistant staphylococcus aureus , diabetes mellitus , antibiotic resistance , microbiology and biotechnology , endocrinology , biology , bacteria , genetics
Objectives This study aimed to analyse retrospectively management and outcomes of the diabetic foot osteomyelitis (DFOM) multi-disciplinary team at St Thomas’ Hospital, London. Methods Patients admitted during 2015 with diagnosis of DFOM were included. Data were obtained from medical and microbiology records. Results 275 patients were admitted for DF infection in 2015: 45.1% had OM (75% males). 40% were newly diagnosed with DF ulcer (DFU). 81% patients had X-ray and 28% had MRI. Bone infection was confirmed by MC&S in 53% cases. 930 microbiological isolates were obtained: 63% were Gram-positive microorganisms [ S . aureus and MRSA (~40%), CoNS (20%), and E . faecalis (8%)]. All MRSA were vancomycin and linezolid sensitive. 23.2% isolates were vancomycin-resistant enterococci. 24% isolates were Gram-negative organisms: P . aeruginosa (42%), E . coli (13%), and E . cloacae (12%). Meropenem resistance was low; 5.4% P . aeruginosa , 87.5% A . baumanii . 76% patients received co-amoxiclav; 41% received ≥3 antibiotics; 17% received >3 months antibiotics. Hospital mean-length of stay was 26.1 days. Ulcer time-to-heal was >6 months in 25% patients. 22% ulcers healed without surgery, 60% healed after minor amputation, 12% patients had major amputation. Conclusion Despite current MDT approach, many patients progress to amputation. DF-OM still represents a challenging clinical condition, requiring further study to develop better management guidelines.